Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More


Learn what's happening in the world of Dohmen and our clients
March 01, 2016

Dohmen to attend Perinatal Stem Cell Society’s Annual Conference

Dohmen Life Science Services experts will join the world’s leading perinatal researchers at the Perinatal Stem Cell Society’s 2016 annual conference in Aspen, Colorado.
learn more
February 29, 2016

Rare Disease Day 2016 - Headlines hide the value of orphan drugs

Thirty million people in America are impacted by rare disease and 95% of those disorders lack treatment. Don’t let the headlines mislead you. The real news is that continued investment in rare disease innovation helps everyone.
learn more
February 25, 2016

Rare Disease Day Matters

You may not be as familiar with Rare Disease Day, held on the last day of February every year to raise awareness of rare diseases. This year, it even falls on the very rare Leap Day. We care and you should too.
learn more
February 17, 2016

Dohmen Company Foundation unveils HealthHero App to help Milwaukee youth

Dohmen Company Foundation & City Leaders unveil HealthHero to help improve the lives of Milwaukee youth.
learn more
November 24, 2015

Viewpoint: Up next: Rare-disease precision marketing

Let's call it precision marketing. Companies that succeed with orphan drugs will be those that can make the paradigm shift from traditional pharmaceutical marketing aimed at large disease populations to precision marketing focused on overall patient experience with a robust support program as the centerpiece.
learn more
November 02, 2015

Owning Leadership: LaConte Transforms Dohmen

“Own leadership.” That is the No. 1 piece of leadership advice Cynthia LaConte, president and chief executive officer of The Dohmen Co., gives to others.
learn more
September 17, 2015

Panel: Talent, institutional buy-in keys to growing biosciences in WI

In a panel discussion on growing the biosciences in Wisconsin, CEOs of four companies emphasized the importance of reeling in top-tier employees and called on institutions, including the state’s legislature and flagship university, to do more for the industry.
learn more
September 17, 2015

Panel tackles barriers, opportunities for women in biosciences

Women make up roughly 75 percent of the U.S. healthcare workforce, according to the federal Bureau of Labor Statistics. And they make as much as 90 percent of the medical decisions for their families, according to some studies. Yet women hold top leadership positions in just 5 percent of healthcare companies, Wendy White, president of the Healthcare Businesswomen's Association, said Wednesday afternoon at the Wisconsin Bioscience Summit.
learn more